September 12th 2024
The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Therapies for infantile hemangiomas need more clinical studies
May 1st 2011Despite recent advances, topical and systemic treatments for infantile hemangiomas need more randomized, controlled trials to help guide treatment decisions. Topical medications generally work best for localized, superficial hemangiomas, says Maria Garzon, M.D., professor of clinical dermatology and clinical pediatrics, Columbia University, New York.
Continuing medical education changes include physician self-evaluation
April 1st 2011Physicians immersed in the world of continuing medical education (CME) say big changes are happening. And doctors of all specialties, including dermatology, will be affected by the emerging CME focus: individual outcomes improvement.
Off-label propranolol for pediatric hemangiomas carries risks
April 1st 2011Determining the proper course of treatment of hemangiomas in pediatric patients can be difficult, as clinical data are sparse. Propranolol has become increasingly popular for off-label treatment, but it comes with significant risks, says Beth A. Drolet, M.D., professor of pediatrics and dermatology, vice chairwoman of dermatology, Medical College of Wisconsin, Milwaukee.
Physicians disagree on appropriate age for laser treatment of port wine stains
April 1st 2011After more than 20 years of widespread use, pulsed-dye lasers remain the therapy of choice in treating port wine stains in children and infants. Still, there have been no significant developments in recent years, and there is some disagreement regarding when treatment of port wine stains should begin.
Suspected pediatric melanomas should be biopsied as they would be in adults
April 1st 2011Pediatric melanomas are uncommon, but because melanoma is not always as easily diagnosed in children as in adults, it is critical to perform biopsies for pediatric patients just as one would for adults, an expert says.
Children susceptible to bedbug, lice infestations
April 1st 2011Pediatric patients are threatened by infestations such as bedbugs, head lice and scabies, so parents need to be vigilant of these risks, according to the chief of the division of pediatric dermatology at the Children’s Hospital of Pittsburgh.
Collaborative seeks protocols, data for pediatric dermatoses therapies
January 1st 2011Evidence-based treatment options for moderate-to-severe pediatric atopic dermatitis and psoriasis are severely limited, according to specialists in the field, leading to the creation of a national collaborative by several pediatric dermatologists.
Some pediatric oral lesions carry serious consequences
December 1st 2010Although most oral lesions observed in children pose little health risk, some of these lesions may be severe and followed by permanent sequelae, an expert says. And some pediatric oral lesions can provide clues to the presence of a systemic disease, she adds.
Pediatric capillary malformations respond to pulsed dye laser therapy
October 1st 2010The pulsed dye laser (PDL) can treat capillary malformations in children and, in exceptional circumstances, infantile hemangiomas, according to a professor of dermatology and pediatrics at the Medical College of Wisconsin, Milwaukee.
Onychomycosis in children difficult to treat without proper diagnosis
October 1st 2010Pediatric onychomycosis is relatively uncommon, with an overall prevalence among all patients with onychomycosis of about 2.5 percent. The condition occurs more often in adolescents than in young children, says Amy Paller, M.D., Walter J. Hamlin Professor, chairwoman of dermatology, professor of pediatrics, Northwestern University Feinberg School of Medicine, Chicago.
Giant congenital nevi may pose threat of melanoma
September 1st 2010If congenital nevi are small, there is insufficient evidence to suggest they should be removed, for they are not likely to transform into melanoma, according to the chief dermatologist at Phoenix Children's Hospital, Phoenix. However, giant nevi present a much higher risk, says Ron Hansen, M.D., F.A.A.D., a board-certified dermatologist and board-certified pediatrician.
Accurate diagnosis of infantile birthmarks crucial to avoid complications
July 1st 2010Vascular birthmarks are very ccommon in newborns, and some varieties affect up to 50 percent of babies. But the challenge for dermatologists can be the early diagnosis and the ability to distinguish the subtle differences between a banal birthmark and one that calls for quick action.
Neonatal dermatoses: Some are cause for more concern than others
April 1st 2010Wailea, Hawaii - The level of concern for neonatal dermatoses ranges depending on the type of condition, according to Julie V. Schaffer, M.D., director of pediatric dermatology, director of resident education, assistant professor of pediatrics and dermatology, NYU Langone Medical Center, New York.
Pediatric dermatology training requirements evolve
April 1st 2010With interest in the new subspecialty of pediatric dermatology still less than robust, leaders in the field are looking at training requirements to see how they might be impacting recruiting. Meanwhile, the window is closing for a small but well-qualified group of physicians to be "grandfathered" into board certification.
Which cosmetic procedures are appropriate for young patients?
April 1st 2010Pediatric patients seek many of the same cosmetic procedures that their parents desire. The question, according to one expert, becomes whether dermatologists and others should perform cosmetic procedures on patients who are still growing - physically and mentally.
Pediatric dermatology, a growing subspecialty, faces challenges
April 1st 2010Pediatric dermatology has achieved important milestones in recent years, including board certification. However, the small dermatology subspecialty stands at a crossroads in 2010. Faced with a significant shortage of physicians choosing a career in pediatric dermatology, those committed to the subspecialty's survival are searching for solutions.
Pediatric dermatoses: Off-label biologic use carries risks, benefits
April 1st 2010Psoriasis in adults is among the most-researched inflammatory skin diseases. Yet treatment options for moderate-to-severe atopic dermatitis and psoriasis in children represents a largely unmet medical need, according to an expert.
Off-label use of propranolol for infantile hemangioma requires watchful eye
April 1st 2010Pediatric dermatologists are taking a very slow - but hopeful - approach to using propranolol to treat hemangiomas in children. In doing so, they are also carefully monitoring children for possible unwanted reactions such as hypotension, bradycardia and hypoglycemia.
Understanding of childhood skin issues deepens
February 3rd 2010Key advances in pediatric dermatology include a deeper understanding of the role of propranolol in treating hemangiomas and of the link between attention deficit hyperactivity disorder (ADHD) and atopic dermatitis (AD), according to an expert. Meanwhile, research into other pediatric issues, including diet and acne, continues.
Dermatologist travels to help HIV-positive children, returns with new perspective
February 3rd 2010Dr. Ondo, clinical assistant professor of dermatology, University of New Mexico, Albuquerque, traveled 30 hours each way on a two-week journey to Hyderabad, near India's southeastern coast. He described the experience as interesting, memorable, and at times overwhelming.